HEATHER STEELE: Open Payments
NPI 1194256065 · MILLERSVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,137 in 94 payments from 21 companies in 2025. Trend: 2023 $1,994 · 2024 $1,590 · 2025 $2,137
Food & beverage: $1,965Education: $172
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 17 | $415 |
| Janssen Biotech, Inc. | 11 | $297 |
| GENZYME CORPORATION | 8 | $241 |
| Novartis Pharmaceuticals Corporation | 10 | $158 |
| Amgen Inc. | 11 | $151 |
| Galderma Laboratories, L.P. | 5 | $104 |
| SANOFI-AVENTIS U.S. LLC | 1 | $97 |
| Organon LLC | 3 | $87 |
| UCB, Inc. | 3 | $83 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 4 | $71 |
Products named: DUPIXENT, ADBRY, TREMFYA, OTEZLA, COSENTYX, NEMLUVIO, Bimzelx, Cabtreo.
Industry payments across MD — which companies pay providers there.
